Abstract
A low-dosage ketoprofen preparation was evaluated in a group of patients with OA of the knees, in a dose of 75 mg daily, for 2 weeks.
Improvement in the criteria used for measurement of therapeutic response was impressive and no adverse effects were seen or reported by patients who took part in this study.
Get full access to this article
View all access options for this article.